BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32604839)

  • 1. CRISPR-Mediated Non-Viral Site-Specific Gene Integration and Expression in T Cells: Protocol and Application for T-Cell Therapy.
    Odé Z; Condori J; Peterson N; Zhou S; Krenciute G
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32604839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing.
    Balke-Want H; Keerthi V; Gkitsas N; Mancini AG; Kurgan GL; Fowler C; Xu P; Liu X; Asano K; Patel S; Fisher CJ; Brown AK; Tunuguntla RH; Patel S; Sotillo E; Mackall CL; Feldman SA
    Mol Cancer; 2023 Jun; 22(1):100. PubMed ID: 37365642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions enhance virus-free generation of
    Kath J; Du W; Pruene A; Braun T; Thommandru B; Turk R; Sturgeon ML; Kurgan GL; Amini L; Stein M; Zittel T; Martini S; Ostendorf L; Wilhelm A; Akyüz L; Rehm A; Höpken UE; Pruß A; Künkele A; Jacobi AM; Volk HD; Schmueck-Henneresse M; Stripecke R; Reinke P; Wagner DL
    Mol Ther Methods Clin Dev; 2022 Jun; 25():311-330. PubMed ID: 35573047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized two-step electroporation process to achieve efficient nonviral-mediated gene insertion into primary T cells.
    Yang M; Tkach D; Boyne A; Kazancioglu S; Duclert A; Poirot L; Duchateau P; Juillerat A
    FEBS Open Bio; 2022 Jan; 12(1):38-50. PubMed ID: 34510816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.
    Eyquem J; Mansilla-Soto J; Giavridis T; van der Stegen SJ; Hamieh M; Cunanan KM; Odak A; Gönen M; Sadelain M
    Nature; 2017 Mar; 543(7643):113-117. PubMed ID: 28225754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Tripartite Gene Editing Machinery for Highly Efficient Non-Viral Targeted Genome Integration.
    Nam H; Xie K; Majumdar I; Yang S; Starzyk J; Lee D; Shan R; Li J; Wu H
    Res Sq; 2023 Oct; ():. PubMed ID: 37961210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-efficiency of genetic modification using CRISPR/Cpf1 system for engineered CAR-T cell therapy.
    Ding R; Chao CC; Gao Q
    Methods Cell Biol; 2022; 167():1-14. PubMed ID: 35152989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Delivery of Chimeric Antigen Receptor into T Cells via CRISPR-Mediated Homology-Directed Repair with a Dual-AAV6 Transduction System.
    Moço PD; Farnós O; Sharon D; Kamen AA
    Curr Issues Mol Biol; 2023 Sep; 45(10):7705-7720. PubMed ID: 37886930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.
    Mollanoori H; Shahraki H; Rahmati Y; Teimourian S
    Hum Immunol; 2018 Dec; 79(12):876-882. PubMed ID: 30261221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TESOGENASE, An Engineered Nuclease Editor for Enhanced Targeted Genome Integration.
    Nam H; Xie K; Majumdar I; Yang S; Starzyk J; Lee D; Shan R; Li J; Wu H
    bioRxiv; 2023 Aug; ():. PubMed ID: 37693500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes.
    Wang B; Li K; Wang A; Reiser M; Saunders T; Lockey RF; Wang JW
    Biotechniques; 2015 Oct; 59(4):201-2, 204, 206-8. PubMed ID: 26458548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of CRISPR/Cas9-Mediated Knock-in System for Porcine Cells with High Efficiency.
    Zhang J; Zhu Z; Yue W; Li J; Chen Q; Yan Y; Lei A; Hua J
    Appl Biochem Biotechnol; 2019 Sep; 189(1):26-36. PubMed ID: 30859452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated homology-directed repair by ssODNs in zebrafish induces complex mutational patterns resulting from genomic integration of repair-template fragments.
    Boel A; De Saffel H; Steyaert W; Callewaert B; De Paepe A; Coucke PJ; Willaert A
    Dis Model Mech; 2018 Oct; 11(10):. PubMed ID: 30355591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A system for site-specific integration of transgenes in mammalian cells.
    Chi X; Zheng Q; Jiang R; Chen-Tsai RY; Kong LJ
    PLoS One; 2019; 14(7):e0219842. PubMed ID: 31344144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-Associated Viral Vectors for Homology-Directed Generation of CAR-T Cells.
    Moço PD; Aharony N; Kamen A
    Biotechnol J; 2020 Jan; 15(1):e1900286. PubMed ID: 31642193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas-based CAR-T cells: production and application.
    Song P; Zhang Q; Xu Z; Shi Y; Jing R; Luo D
    Biomark Res; 2024 May; 12(1):54. PubMed ID: 38816881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated homology-directed targeted integration of transgenes in Chinese hamster ovary cells via CRISPR/Cas9 and fluorescent enrichment.
    Lee JS; Grav LM; Pedersen LE; Lee GM; Kildegaard HF
    Biotechnol Bioeng; 2016 Nov; 113(11):2518-23. PubMed ID: 27159230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-viral chimeric antigen receptor (CAR) T cells going viral.
    Balke-Want H; Keerthi V; Cadinanos-Garai A; Fowler C; Gkitsas N; Brown AK; Tunuguntla R; Abou-El-Enein M; Feldman SA
    Immunooncol Technol; 2023 Jun; 18():100375. PubMed ID: 37124148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T Cells.
    Hale M; Lee B; Honaker Y; Leung WH; Grier AE; Jacobs HM; Sommer K; Sahni J; Jackson SW; Scharenberg AM; Astrakhan A; Rawlings DJ
    Mol Ther Methods Clin Dev; 2017 Mar; 4():192-203. PubMed ID: 28345004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells.
    MacLeod DT; Antony J; Martin AJ; Moser RJ; Hekele A; Wetzel KJ; Brown AE; Triggiano MA; Hux JA; Pham CD; Bartsevich VV; Turner CA; Lape J; Kirkland S; Beard CW; Smith J; Hirsch ML; Nicholson MG; Jantz D; McCreedy B
    Mol Ther; 2017 Apr; 25(4):949-961. PubMed ID: 28237835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.